Publications - 'S'

Publications 26 - 50 de 2428
| % | ( | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | < | ? | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | [ | ` | {
Titre DOI
SAFETY AND EFFICACY OF ALL-ORAL DAA REGIMENS IN HIV-HCV COINFECTED CIRRHOTIC PATIENTS FROM THE PROSPECTIVE ANRS CO13-HEPAVIH COHORT
P. Sogni; C. Gilbert; K. Lacombe; L. Piroth; E. Rosenthal; S. Dominguez; J. Chas; D. Neau; I. Poizot-Martin; G. Hasenknopf; P. Morlat; A. Simon; D. Zucman; H. Aumaitre; C. Lascoux-Combe; L. Esterle; F. Dabis; L. Wittkop; D. Salmon-Ceron; C.O.13H.E.P.A.V.I.H. Cohort
2015 		10.1016/S0168-8278(15)30174-4
Safety and efficacy of daclatasvir-sofosbuvir in HCV genotype 1-mono-infected patients
S. Pol; M. Bourliere; S. Lucier; C. Hezode; C. Dorival; D. Larrey; J.P. Bronowicki; V.D.E. Ledinghen; F. Zoulim; A. Tran; S. Metivier; J.P. Zarski; D. Samuel; D. Guyader; P. Marcellin; A. Minello; L. Alric; D. Thabut; O. Chazouilleres; G. Riachi; V. Bourcier; P. Mathurin; V. Loustaud-Ratti; L. d'Alteroche; I. Fouchard-Hubert; F. Habersetzer; X. Causse; C. Geist; I. Rosa; J. Gournay; E. Saillard; E. Billaud; V. Petrov-Sanchez; A. Diallo; H. Fontaine; F. Carrat; A.N.R.S.A.F.E.F.H.E.P.A.T. Grp
2017 		10.1016/j.jhep.2016.08.021
Safety and efficacy of Dimethylfumarate in relapsing remitting multiple sclerosis: a real life regional study
M. Bereau; O. Sandoz; C. Clerc; A. Jary; F. Ziegler; E. Berger; L. Chamard-Witkowsky; E. Magnin; E. Toussirot; M.B. Valnet-Rabier
2017
Safety and efficacy of flow-diverter stents in endovascular treatment of intracranial aneurysm: Interest of the prospective DIVERSION observational study
B. Gory; A. Bonafe; L. Pierot; L. Spelle; J. Berge; M. Piotin; C. Mounayer; A. Biondi; P. Courtheoux; C. Cognard; H. Desal; D. Herbreteaux; J. Gabrillargues; F. Ricolfi; N. Sourour; J. Sedat; S. Gallas; K. Boubagra; L. Huot; S. Embarek; Z. Kulcsar; C. Taschner; F. Chapuis; F. Turjman
2014 		10.1016/j.neurad.2013.12.003
Safety and Efficacy of Gemcitabine, Docetaxel, Capecitabine, Cisplatin as Second-line Therapy for Advanced Pancreatic Cancer After FOLFIRINOX
J.D. Fumet; J. Vincent; L. Bengrine; A. Hennequin; L. Granconato; R. Palmier; F. Ghiringhelli
2020 		10.21873/anticanres.14395
SAFETY AND EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH CANCER AND PREEXISTING AUTOIMMUNE DISEASES: A NATIONWIDE MULTICENTER RETROSPECTIVE STUDY
A. Tison; G. Quere; L. Misery; E. Funck-Brentano; F.X. Danlos; B. Bonniaud; C. Scalbert; T. Lesimple; S. Martinez; M. Marcq; C. Chouaid; C. Dubos; F. Brunet-Possenti; C. Stavris; L.Y. Chiche; D. Cornec; M. Kostine; GCC; GFPC; CRI
2018 		10.1136/annrheumdis-2018-eular.5840
Safety and efficacy of intensity-modulated radiotherapy in the management of spermatic cord sarcoma
T. Cerda; E. Martin; G. Truc; G. Crehange; P. Maingon
2017 		10.1016/j.canrad.2016.07.102
SAFETY AND EFFICACY OF INTRA ARTICULAR INJECTIONS OF A COMBINATION OF HYALURONIC ACID AND MANNITOL (HANOX-M) IN PATIENTS WITH SYMPTOMATIC KNEE OSTEOARTHRITIS. RESULTS OF A DOUBLE-BLIND, CONTROLLED, MULTICENTER, RANDOMIZED TRIAL
T. Conrozier; N. Afif; R. Lecurieux; A. Walliser; X. Chevalier
2016 		10.1016/j.joca.2016.01.966
Safety and efficacy of intra-arterial hepatic chemotherapy with doxorubicin-loaded nanoparticles in hepatocellular carcinoma
P. Merle; P. Camus; A. Abergel; G.Philippe Pageaux; C. Masliah; J.Pierre Bronowicki; J.Pierre Zarski; G. Pelletier; M. Bouattour; L. Farloux; E. Dorval; G. Verset; S.N. Si-Ahmed; M. Doffoel; P. Couzigou; J. Taieb; B. Vasseur; P. Attali
2017 		10.1136/esmoopen-2017-000238
Safety and efficacy of intra-articular injections of a combination of hyaluronic acid and mannitol (HAnOX-M) in patients with symptomatic knee osteoarthritis Results of a double-blind, controlled, multicenter, randomized trial
T. Conrozier; F. Eymard; N. Afif; J.C. Balblanc; V. Legre-Boyer; X. Chevalier; H.Study Grp
2016 		10.1016/j.knee.2016.05.015
Safety and efficacy of left atrial appendage occlusion guided by CT-scan and intracardiac echocardiography from the left atrium
R.R. Robert; T.P. Pommier; C.V. Vernay; P.B. Buffet; C.R. Richard; C.G. Guenancia; Y.C. Cottin; L. Lorgis
2018
Safety and efficacy of left atrial appendage occlusion with the ACP or Watchman device guided by intracardiac echocardiography from the left atrium
T. Pommier; C. Guenancia; C. Richard; A. Sagnard; M. Fichot; C. Salignon-Vernay; G. Porot; G. Laurent; L. Lorgis
2021 		10.1002/clc.23696
Safety and efficacy of local versus general anesthesia in patients undergoing transcatheter aortic valve implantation using a transfemoral approach: VARC- defined outcomes in the FRANCE 2 registry
R. Chopard; N. Meneveau; S. Chocron; M.F. Seronde; M. Gilard; M. Laskar; H. Eltchaninoff; B. Iung; P. Leprince; F. Schiele
2014
Safety and efficacy of local versus general anesthesia in patients undergoing transcatheter aortic valve implantation using a transfemoral approach: VARC- defined outcomes in the FRANCE 2 registry
R. Chopard; N. Meneveau; S. Chocron; M.F. Seronde; M. Gilard; M. Laskar; H. Eltchaninoff; B. Iung; P. Leprince; F. Schiele
2014
SAFETY AND EFFICACY OF LOCAL VERSUS GENERAL ANESTHESIA IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE IMPLANTATION USING A TRANSFEMORAL APPROACH: VARC-DEFINED OUTCOMES IN THE FRANCE 2 REGISTRY
R. Chopard; N. Meneveau; S. Chocron; M.F. Seronde; M. Gilard; M. Laskar; H. Eltchaninoff; B. Iung; P. Leprince; E. Teiger; K. Chevreul; A. Prat; M. Lievre; A. Leguerrier; P. Donzeau-Gouge; J. Fajadet; F. Schiele
2014 		10.1016/S0735-1097(14)61929-X
Safety and efficacy of low-dose PI3K inhibitor taselisib in adult patients with CLOVES and Klippel-Trenaunay syndrome (KTS): the TOTEM trial, a phase 1/2 multicenter, open-label, single-arm study
M. Luu; P. Vabres; H. Devilliers; R. Loffroy; A. Phan; L. Martin; F. Morice-Picard; F. Petit; M. Willems; D. Bessis; M.L. Jacquemont; A. Maruani; C. Chiaverini; T. Mirault; J. Clayton-Smith; M. Carpentier; C. Fleck; A. Maurer; M. Yousfi; V.E.R. Parker; R.K. Semple; M. Bardou; L. Faivre
2021 		10.1038/s41436-021-01290-y
Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum
V.E.R. Parker; K.M. Keppler-Noreuil; L. Faivre; M. Luu; N.L. Oden; L. De Silva; J.C. Sapp; K. Andrews; M. Bardou; K.Y. Chen; T.N. Darling; E. Gautier; B.R. Goldspiel; S. Hadj-Rabia; J. Harris; G. Kounidas; P. Kumar; M.J. Lindhurst; R. Loffroy; L. Martin; A. Phan; K.I. Rother; B.C. Widemann; P.L. Wolters; C. Coubes; L. Pinson; M. Willems; C. Vincent-Delorme; P. Vabres; R.K. Semple; L.G. Biesecker; P.R.O.M.I.S.E.Working Grp
2019 		10.1038/s41436-018-0297-9
Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study
R. Flippot; C. Dalban; B. Laguerre; D. Borchiellini; G. Gravis; S. Negrier; C. Chevreau; F. Joly; L. Geoffrois; S. Ladoire; H. Mahammedi; F. Rolland; M. Gross-Goupil; E. Deluche; F. Priou; M. Laramas; P. Barthelemy; B. Narciso; N. Houede; S. Culine; S. Oudard; M. Chenot; F. Tantot; S. Chabaud; B. Escudier; L. Albiges
2019 		10.1200/JCO.18.02218
Safety and efficacy of nivolumab in metastatic renal cell carcinoma (mRCC): Final analysis from the NIVOREN GETUG AFU 26 study.
L. Albiges; S. Negrier; C. Dalban; C. Chevreau; G. Gravis; S. Oudard; B. Laguerre; P. Barthelemy; D. Borchiellini; M. Gross-Goupil; L. Geoffrois; F. Rolland; A. Thiery-Vuillemin; F. Joly; S. Ladoire; F. Tantot; B. Escudier
2019 		10.1200/JCO.2019.37.7_suppl.542
Safety and efficacy of nivolumab in older patients (pts) with renal cell carcinoma: Results of a sub-group analysis of the GETUG-AFU 26 NIVOREN multicenter phase II study.
L. Mourey; C. Dalban; S. Negrier; C. Chevreau; G. Gravis; C. Thibault; B. Laguerre; P. Barthelemy; D. Borchiellini; M. Gross-Goupil; L. Geoffrois; F. Rolland; A. Thiery-Vuillemin; F. Joly; S. Ladoire; F. Tantot; B. Escudier; L. Albiges
2021 		10.1200/JCO.2021.39.6_suppl.331
Safety and Efficacy of Peripheral Embolization with EASYX Liquid Embolic Agent: A Multicenter Prospective Study
M. Sapoval; V. Vidal; C. Dean; C. Del Giudice; F. Tradi; O. Chevallier; A. Charles-Nelson; O. Pellerin; R. Loffroy
2021 		10.1016/j.jvir.2021.05.014
Safety and efficacy of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis and carrying a telomere-related gene mutation
A. Justet; D. Klay; R. Porcher; V. Cottin; K. Ahmad; M.Molina Molina; H. Nunes; M. Reynaud-Gaubert; J.Marc Naccache; E. Manali; A. Froidure; S. Jouneau; L. Wemeau; C. Andrejak; A. Gondouin; S. Hirschi; E. Blanchard; B. Bondue; P. Bonniaud; C. Tromeur; G. Prevot; S. Marchand-Adam; M. Funke-Chambour; A.Sophie Gamez; I. Ba; S. Papiris; J. Grutters; B. Crestani; C. van Moorsel; C. Kannengiesser; R. Borie; O.L. Network
2021 		10.1183/13993003.03198.2020
Safety and efficacy of pirfenidone in patients carrying telomerase complex mutation
A. Justet; G. Thabut; E. Manali; M.Molina Molina; C. Kannengiesser; J. Cadranel; V. Cottin; A. Gondouin; H. Nunes; E. Magois; C. Tromeur; G. Prevot; S. Papiris; S. Marchand-Adam; A.Sophie Gamez; M. Reynaud-Gaubert; L. Wemeau; B. Crestani; R. Borie
2018 		10.1183/13993003.01875-2017
Safety and Efficacy of PRTX-100, a Highly Purified Form of Staphylococcal Protein A, in Patients with Immune Thrombocytopenia (ITP)
J.B. Bussel; D.J. Kuter; S. Audia; R.J. Francovitch; M. Michel
2016 		10.1182/blood.V128.22.4929.4929
Safety and efficacy of regorafenib in patients with advanced soft tissue sarcoma (REGOSARC): a randomised, double-blind, placebo-controlled, phase 2 trial
O. Mir; T. Brodowicz; A. Italiano; J. Wallet; J.Y. Blay; F. Bertucci; C. Chevreau; S. Piperno-Neumann; E. Bompas; S. Salas; C. Perrin; C. Delcambre; B. Liegl-Atzwanger; M. Toulmonde; S. Dumont; I. Ray-Coquard; S. Clisant; S. Taieb; C. Guillemet; M. Rios; O. Collard; L. Bozec; D. Cupissol; E. Saada-Bouzid; C. Lemaignan; W. Eisterer; N. Isambert; L. Chaigneau; A. Le Cesne; N. Penel
2016 		10.1016/S1470-2045(16)30507-1

Pages